EUVIMEDEUVIMED entdecken
Crossref

Bimetal‐Biligand Frameworks for Spatiotemporal Nitric Oxide‐Enhanced Sono‐Immunotherapy

Yu Cheng, Wenbin Zhong, Yun Chen, Brynne Shu Ni Tan, Yue Zhao, Jingjing Guo, Mengmeng Ma, Yanli Zhao iD

Advanced Materials · 2024-11 · 36 (45)

DOI: 10.1002/adma.202408242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 03.09.2024. Verfasst von Yu Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, 637371, Singapore. Hauptthemen laut MEDLINE: Immunotherapy, Nitric Oxide, Metal-Organic Frameworks. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Research Foundation Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sonodynamic therapy can trigger immunogenic cell death to augment immunotherapy, benefiting from its superior spatiotemporal selectivity and non‐invasiveness. However, the practical applications of sonosensitizers are hindered by their low efficacy in killing cancer cells and activating immune responses. Here, two US Food and Drug Administration‐approved drug ligands (ferricyanide and nitroprusside) and two types of metals (copper/iron) are selected to construct a bimetal‐biligand framework (Cu[PBA‐NO]). Through elaborate regulation of multiple metal/ligand coordination, the systemically administered Cu[PBA‐NO] nanoagent shows sono‐catalytic and NO release ability under ultrasound irradiation, which can be used for effective sono‐immunotherapy. Moreover, Cu[PBA‐NO] can downregulate intracellular glutathione levels that would destroy intracellular redox homeostasis and facilitate reactive oxygen species accumulation. The released tumor‐associated antigens subsequently facilitate dendritic cell maturation within the tumor‐draining lymph node, effectively initiating a T cell‐mediated immune response and thereby bolstering the capacity to identify and combat cancer cells. This study paves a new avenue for the efficient cancer sono‐immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNitric OxideMetal-Organic FrameworksAnimalsMiceHumansCell Line, TumorCopperReactive Oxygen SpeciesUltrasonic TherapyLigandsDendritic CellsNeoplasmsGlutathione

Stichwörter der Autor:innen

bimetal‐biligand frameworkscancer treatmentimmunotherapynitric oxidesonodynamic therapy

Substanzen

Nitric OxideMetal-Organic FrameworksCopperReactive Oxygen SpeciesLigandsGlutathione

Autor:innen und Institutionen

  • School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, 637371, Singapore.

ORCID-Profile: Yanli Zhao

Förderung

  • National Research Foundation Singapore

Zitieren

APA

Cheng, Y., Zhong, W., Chen, Y., Tan, B. S. N., Zhao, Y., Guo, J., Ma, M., & Zhao, Y. (2024). Bimetal‐Biligand Frameworks for Spatiotemporal Nitric Oxide‐Enhanced Sono‐Immunotherapy. Advanced Materials, 36(45). https://doi.org/10.1002/adma.202408242

Vancouver

Cheng Y, Zhong W, Chen Y, Tan BSN, Zhao Y, Guo J, et al. Bimetal‐Biligand Frameworks for Spatiotemporal Nitric Oxide‐Enhanced Sono‐Immunotherapy. Advanced Materials. 2024;36(45). doi:10.1002/adma.202408242

BibTeX
@article{Cheng2024,
  author = {Cheng, Yu and Zhong, Wenbin and Chen, Yun and Tan, Brynne Shu Ni and Zhao, Yue and Guo, Jingjing and Ma, Mengmeng and Zhao, Yanli},
  title = {Bimetal‐Biligand Frameworks for Spatiotemporal Nitric Oxide‐Enhanced Sono‐Immunotherapy},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {45},
  doi = {10.1002/adma.202408242}
}
Kostenlos starten →